David Tepper
Appaloosa Management
David Tepper Valeant Pharmaceuticals International Inc stake
total: 317
Appaloosa Management VRX trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2016 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2016 Q2
According to 2026 Q2 report, David Tepper doesn't hold any Valeant Pharmaceuticals International Inc (VRX) shares. To date, the estimated cost basis is nearly $26.3 for "buy" trades and estimated average "sell" price is $26.3. Appaloosa Management first purchased VRX in 2016 Q1, initially acquiring 945,000 shares. Since the initial investment in Valeant Pharmaceuticals International Inc (VRX), Appaloosa Management has made 1 more transaction.
When did David Tepper sell Valeant Pharmaceuticals International Inc (VRX)?
David Tepper sold off the entire Valeant Pharmaceuticals International Inc (VRX) position in 2016 Q2.
When did David Tepper buy Valeant Pharmaceuticals International Inc (VRX)?
David Tepper first invested in Valeant Pharmaceuticals International Inc (VRX) in 2016 Q1 at the reported quarter-end price of $26.30 per share.
What's the cost basis of Appaloosa Management's VRX stake?
The estimated cost basis for Valeant Pharmaceuticals International Inc (VRX) stake is around $26.30 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $26.30
- Weighted AVG sell price:
- $26.30
David Tepper's historical trades in Valeant Pharmaceuticals International Inc
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.